The Impact of Diurnal Fasting During Ramadan on Patients with Established Cardiac Disease: A Systematic Review
Keywords:Ramadan Fasting, Cardiac Disease, Cardiovascular Risk Factors
During the month of Ramadan, Muslims abstain from eating before dawn until after sunset for a month. This study reviews most recent literature on the effect of Ramadan fasting on the Cardiac patient specifically, excluding any study done on patients with no diagnosis of Cardiac disease to help cardiologists better deal with their patients who would wish to fast during Ramadan. As such, a Medline and Pubmed search was conducted to retrieve studies investigating the effects of fasting during Ramadan specifically on the cardiac patient with regard to incidence of cardiac disease and change in cardiovascular risk parameters. The search was conducted by combining the key word “Ramadan Fasting” with multiple cardiac diseases and cardiovascular risk parameters. Only studies reporting results on patients already diagnosed with a cardiac disease were included. fourteen were included. Most studies have shown, with a few exceptions, that Ramadan fasting has no adverse effects on incidence of cardiovascular disease or the number of hospitalizations due to cardiac disease events. Thus patients with controlled disease may fast with the consultation and monitoring of their physician.
Cheng C-W, Adams GB, Perin L, Wei M, Zhou X, Lam BS, et al. Prolonged fasting reduces IGF-1/PKA to promote hematopoietic-stem-cell-based regeneration and reverse immunosuppression. Cell stem cell. 2014;14:810-23.
Cheng C-W, Villani V, Buono R, Wei M, Kumar S, Yilmaz OH, et al. Fasting-mimicking diet promotes Ngn3-driven β-cell regeneration to reverse diabetes. Cell. 2017;168:775-88. e12.
Laviano A, Rossi Fanelli F. Toxicity in chemotherapy—when less is more. New England Journal of Medicine. 2012;366:2319-20.
Lee C, Longo V. Fasting vs dietary restriction in cellular protection and cancer treatment: from model organisms to patients. Oncogene. 2011;30:3305-16.
Levine ME, Suarez JA, Brandhorst S, Balasubramanian P, Cheng C-W, Madia F, et al. Low protein intake is associated with a major reduction in IGF-1, cancer, and overall mortality in the 65 and younger but not older population. Cell metabolism. 2014;19:407-17.
Raffaghello L, Lee C, Safdie FM, Wei M, Madia F, Bianchi G, et al. Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy. Proceedings of the National Academy of Sciences. 2008;105:8215-20.
Safdie F, Brandhorst S, Wei M, Wang W, Lee C, Hwang S, et al. Fasting enhances the response of glioma to chemo-and radiotherapy. PloS one. 2012;7:e44603.
Safdie FM, Dorff T, Quinn D, Fontana L, Wei M, Lee C, et al. Fasting and cancer treatment in humans: A case series report. Aging [Albany NY]. 2009;1:988.
Di Biase S, Lee C, Brandhorst S, Manes B, Buono R, Cheng C-W, et al. Fasting-mimicking diet reduces HO-1 to promote T cell-mediated tumor cytotoxicity. Cancer cell. 2016;30:136-46.
Brandhorst S, Choi IY, Wei M, Cheng CW, Sedrakyan S, Navarrete G, et al. A periodic diet that mimics fasting promotes multi-system regeneration, enhanced cognitive performance, and healthspan. Cell metabolism. 2015;22:86-99.
Choi IY, Piccio L, Childress P, Bollman B, Ghosh A, Brandhorst S, et al. A diet mimicking fasting promotes regeneration and reduces autoimmunity and multiple sclerosis symptoms. Cell reports. 2016;15:2136-46.
Parrella E, Maxim T, Maialetti F, Zhang L, Wan J, Wei M, et al. Protein restriction cycles reduce IGF‐1 and phosphorylated Tau, and improve behavioral performance in an Alzheimer's disease mouse model. Aging cell. 2013;12:257-68.
Al Suwaidi J, Bener A, Suliman A, Hajar R, Salam A, Numan M, et al. A population based study of Ramadan fasting and acute coronary syndromes. Heart. 2004;90:695-6.
Talib S, van de Poll SW. Brugada syndrome diagnosed after Ramadan. Lancet. 2013 Jul 06;382:100. PubMed PMID: 23830342. English.
Siegel AJ, Bhatti NA, Wasfy JH. Reprising Ramadan-Related Angina Pectoris: A Potential Strategy for Risk Reduction. The American Journal of Case Reports. 2016 Nov 10;17:841-4. PubMed PMID: 27829657. English.
Al Suwaidi J, Bener A, Hajar HA, Numan MT. Does hospitalization for congestive heart failure occur more frequently in Ramadan: a population-based study [1991-2001]. International Journal of Cardiology. 2004 Aug;96:217-21. PubMed PMID: 15262036. English.
Al Suwaidi J, Zubaid M, Al-Mahmeed WA, Al-Rashdan I, Amin H, Bener A, et al. Impact of fasting in Ramadan in patients with cardiac disease. Saudi Medical Journal. 2005 Oct;26:1579-83. PubMed PMID: 16228059. English.
Bener A, Hamad A, Fares A, Al-Sayed HM, Al-Suwaidi J. Is there any effect of Ramadan fasting on stroke incidence? Singapore Medical Journal. 2006 May;47:404-8. PubMed PMID: 16645691. English.
Chamsi-Pasha H, Ahmed WH. The effect of fasting in Ramadan on patients with heart disease. Saudi Medical Journal. 2004 Jan;25:47-
PubMed PMID: 14758379. English.
ÇOMOĞLU S, Temizhan A, PEŞİNCİ E, TANDOĞAN İ, ÖZBAKIR Ş. Effects of Ramadan fasting on stroke. Turkish Journal of Medical Sciences. 2003;33:237-41.
El-Mitwalli A, Zaher AA, El Menshawi E. Circadian rhythm of stroke onset during the month of Ramadan. Acta Neurologica Scandinavica. 2010 Aug;122:97-101. PubMed PMID: 19839942. English.
Salam AM, AlBinali HA, Salim I, Singh R, Asaad N, Al-Qahtani A, et al. Impact of religious fasting on the burden of atrial fibrillation: a population-based study. International Journal of Cardiology. 2013 Oct 03;168:3042-3. PubMed PMID: 23642825. English.
Salam AM, Sulaiman K, Alsheikh-Ali AA, Singh R, Asaad N, Al-Qahtani A, et al. Acute heart failure presentations and outcomes during the fasting month of Ramadan: an observational report from seven middle eastern countries. Current medical research and opinion. 2017:1-9.
Mousavi M, Mirkarimi S, Rahmani G, Hosseinzadeh E, Salahi N. Ramadan fast in patients with coronary artery disease. Iranian Red Crescent Medical Journal. 2014;16.
Yousefi B, Faghfoori Z, Samadi N, Karami H, Ahmadi Y, Badalzadeh R, et al. The effects of Ramadan fasting on endothelial function in patients with cardiovascular diseases. European Journal of Clinical Nutrition. 2014 Jul;68:835-9. PubMed PMID: 24755927. English.
Khafaji HA, Bener A, Osman M, Al Merri A, Al Suwaidi J. The impact of diurnal fasting during Ramadan on the lipid profile, hs-CRP, and serum leptin in stable cardiac patients. Vascular Health & Risk Management. 2012;8:7-14. PubMed PMID: 22272070. English.
Nematy M, Alinezhad-Namaghi M, Rashed MM, Mozhdehifard M, Sajjadi SS, Akhlaghi S, et al. Effects of Ramadan fasting on cardiovascular risk factors: a prospective observational study. Nutrition Journal. 2012 Sep 10;11:69. PubMed PMID: 22963582. English.
Al-Shafei AI. Ramadan fasting ameliorates arterial pulse pressure and lipid profile, and alleviates oxidative stress in hypertensive patients. Blood Pressure. 2014 Jun;23:160-7. PubMed PMID: 24059637. English.
Salahuddin M, Sayed Ashfak A, Syed S, Badaam K. Effect of Ramadan fasting on body weight,[BP] and biochemical parameters in middle aged hypertensive subjects: an observational trial. Journal of clinical and diagnostic research: JCDR. 2014;8:16.
Topacoglu H, Karcioglu O, Yuruktumen A, Kiran S, Cimrin A, Ozucelik D, et al. Impact of Ramadan on demographics and frequencies of disease‐related visits in the emergency department. International journal of clinical practice. 2005;59:900-5.
Bursztyn M, Mekler J, Wachtel N, Ben-Ishay D. Siesta and ambulatory blood pressure monitoring Comparability of the afternoon nap and night sleep. American journal of hypertension. 1994;7:217-21.
Chamsi-Pasha H, Ahmed WH, Al-Shaibi KF. The cardiac patient during Ramadan and Hajj. Journal of the Saudi Heart Association. 2014 Oct;26:212-5. PubMed PMID: 25278723. PMCID: 4179898.
Salim I, Al Suwaidi J, Ghadban W, Alkilani H, Salam AM. Impact of religious Ramadan fasting on cardiovascular disease: a systematic review of the literature. Current medical research and opinion. 2013 Apr;29:343-54. PubMed PMID: 23391328.
Adlouni A, Ghalim N, Saı̈le R, Hda N, Parra H-J, Benslimane A. Beneficial effect on serum apo AI, apo B and Lp AI levels of Ramadan fasting. Clinica chimica acta. 1998;271:179-89.
Aksungar FB, Eren A, Ure S, Teskin O, Ates G. Effects of intermittent fasting on serum lipid levels, coagulation status and plasma homocysteine levels. Ann Nutr Metab. 2005 Mar-Apr;49:77-82. PubMed PMID: 15802901. Epub 2005/04/02. eng.
Aksungar FB, Topkaya AE, Akyildiz M. Interleukin-6, C-reactive protein and biochemical parameters during prolonged intermittent fasting. Annals of nutrition & metabolism. 2007;51:88-95. PubMed PMID: 17374948.
Akaberi A, Golshan A, Moojdekanloo M, Hashemian M. Does fasting in Ramadan ameliorate Lipid profile? A prospective observational study. Pakistan journal of medical sciences. 2014;30:708.
Barkia A, Mohamed K, Smaoui M, Zouari N, Hammami M, Nasri M. Change of diet, plasma lipids, lipoproteins, and fatty acids during Ramadan: a controversial association of the considered Ramadan model with atherosclerosis risk. Journal of health, population, and nutrition. 2011;29:486.
Niewada M, Członkowska A. Prevention of ischemic stroke in clinical practice: a role of internists and general practitioners. Polskie Archiwum Medycyny Wewnętrznej. 2014;124:540-8.
Al-Arouj M, Assaad-Khalil S, Buse J, Fahdil I, Fahmy M, Hafez S, et al. Recommendations for management of diabetes during Ramadan. Diabetes care. 2010;33:1895-902.
Salti I, Bénard E, Detournay B, Bianchi-Biscay M, Le Brigand C, Voinet C, et al. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries. Diabetes care. 2004;27:2306-11.
Bravis V, Hui E, Salih S, Mehar S, Hassanein M, Devendra D. Ramadan Education and Awareness in Diabetes [READ] programme for Muslims with Type 2 diabetes who fast during Ramadan. Diabetic Medicine. 2010;27:327-31.
Ibrahim M, Abu Al Magd M, Annabi FA, Assaad-Khalil S, Ba-Essa EM, Fahdil I, et al. Recommendations for management of diabetes during Ramadan: update 2015. BMJ Open Diabetes Research & Care. 2015;3.
Shewan LG, Coats A, Henein M, editors. Requirements for ethical publishing in biomedical journals. International Cardiovascular Forum Journal; 2015.
Authors who publish with this journal agree to the following terms:
a. The authors will retain copyright under a Creative Commons Attribution License (CC-BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).